BRD2 and carcinoma: Analysis of snRNA-seq data validated our spatial transcriptomics findings, and pinpointed CAFs as the primary mediators of this NAT-induced upregulation of complement in TME, while complement gene expression in carcinoma cells and immune cells were not notably changed.